Newman Dignan & Sheerar, Inc. Bio Restorative Therapies, Inc. Transaction History
Newman Dignan & Sheerar, Inc.
- $386 Million
- Q4 2024
A detailed history of Newman Dignan & Sheerar, Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 11,522 shares of BRTX stock, worth $24,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,522
Previous 10,522
9.5%
Holding current value
$24,080
Previous $18,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BRTX
# of Institutions
17Shares Held
282KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA54.7KShares$114,3680.0% of portfolio
-
Stone X Group Inc.50.1KShares$104,7090.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$83,6000.01% of portfolio
-
Morgan Stanley New York, NY27.5KShares$57,4740.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il21.5KShares$44,8950.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $7.63M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...